Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/24 16:48 | 11/1/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Geist William | MN | O | P,Protei | 1 | M.d | 0 | 0.00 | 0 | 10 | 848 | 11 | D | ||||||||||||||
11/5/24 16:46 | 11/1/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 13 | 14 | 107 | D | ||||||||||||||
9/16/24 16:18 | 9/12/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Higgins John L | MN | D | 1 | M.d | 138 | 22.95 | 0 | 6 | 15 | 47 | D | |||||||||||||||
9/3/24 16:05 | 8/29/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Kelderman Kim | MN | DO | CEO | 1 | M.d | 100 | 66.97 | 0 | 1 | 4 | 41 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |